Results 181 to 190 of about 114,562 (319)

Influence of Gut Microbiota on Response to Immune Check Point Inhibitors in MASLD Patients With HCC: Unraveling the Connection

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment for various cancers, including advanced hepatocellular carcinoma (HCC). However, a significant proportion of patients with HCC, particularly those with metabolic dysfunction‐associated liver disease (MASLD), exhibit resistance to ICI therapy.
Mazen Elsheikh, Mohamad Ali Ibrahim, Sherry Fares, Megha Bhongade, Karim Adhem, Ximena I. Ramirez‐Morales, Ahmed O. Kaseb, Joseph Petrosino, Manal M. Hassan, Prasun K. Jalal   +9 more
wiley   +1 more source

Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC). [PDF]

Cancers (Basel)
Staehler M, Blajan I, Aydogdu C, Graser A, Hoffmann M, Brinkmann I, Schulz GB, Yen A, Cheng JJ, Fürweger C, Psutka SP, Hannan R, Muacevic A.   +12 more
europepmc   +1 more source

Artificial intelligence in nongynecologic cytology: A systematic review of current research and commercial tools

Cancer Cytopathology, Volume 134, Issue 4, April 2026.
Abstract Background Nongynecologic (non‐GYN) cytology plays an important role in cellular and molecular cancer diagnosis, although its use is limited by variability and interobserver discrepancies. Recent studies suggest that artificial intelligence (AI) may improve diagnostic consistency and performance.
Tsandmaa Byambadorj, Mohammad Rizwan Alam, Yosep Chong   +2 more
wiley   +1 more source

Urothelial Carcinoma of the Bladder with a Single Pancreatic Metastasis: A Case Report. [PDF]

Reports (MDPI)
Calabrese B, Frego N, Fasulo V, Pinna MS, Taverna G.   +4 more
europepmc   +1 more source

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2) [PDF]

, 2018
et al,, Picus, Joel
core   +1 more source

A Rare Variant of Urothelial Carcinoma: Plasmacytoid Urothelial Carcinoma

Turkiye Klinikleri Journal of Case Reports, 2022
Kazım CEVİZ, Muhammed Emin POLAT, Emre UZUN, Lütfi İhsan BOYACI, Cavit CEYLAN   +4 more
openaire   +1 more source

Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma [PDF]

, 2017
Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Οhyama   +9 more
openalex   +1 more source

Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. [PDF]

J Pers Med
Bilim V, Hoshi S.
europepmc   +1 more source

What Is Your Diagnosis? Fine‐Needle Aspirate From a Lingual Mass in a Cat

Veterinary Clinical Pathology, EarlyView.
Emma Stacey, Andrii Trokoz, Kimberly Williams, Dorothee Bienzle   +3 more
wiley   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head &Neck, Volume 48, Issue 4, Page 932-940, April 2026.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, Andrew Elliott, Ranee Mehra, Heloisa Soares, Emil Lou, Ari Vanderwalde, David Spetzler, Dara Bracken‐Clarke, Nyall R. London Jr., James L. Gulley, Charalampos S. Floudas   +12 more
wiley   +1 more source